Study finds pharma antibiotics polluting rivers
The study conducted by Toxic Links finds Indian rivers contain antibiotic residues that may contribute to the growing problem of 'antimicrobial resistance' and negative effects on the ecosystem and human health
A new study by Toxics Link, ‘Menace of Antibiotic Pollution in Indian Rivers’ has raised serious concerns over antibiotic residues found in river water samples from four Indian rivers, i.e., Yamuna (New Delhi), Gomti (Lucknow), Zuari (Goa) and Cooum (Chennai).
The study finds Indian rivers contain antibiotic residues that may contribute to the growing problem of ‘antimicrobial resistance’ and negative effects on the ecosystem and human health.
Three antibiotics, namely, Ofloxacin, Norfloxacin and Sulfamethoxazole were detected in these river water samples. Ofloxacin (0.71 Aug/L) and Sulfamethoxazole (0.2 Aug/L) were found in the Yamuna and Norfloxacin (0.93 Aug/L) was detected in the Zuari. Ofloxacin (0.54 Aug/L) was also present in the Gomti and Cooum.
“All the antibiotics detected are found to be two-to-five times higher than the draft notification limits proposed by the Ministry of Environment, Forest and Climate Change for the respective compounds,” said Omkar Gaonkar, Programme Coordinator, Toxics Link.
The sample size in this study is limited; however, the findings of this study are alarming and highlight the potential possibility of widespread antibiotic pollution in the country, a release from Toxics Link said.
“Most importantly, the locations where antibiotic residues are detected are not necessarily in close proximity to major pharmaceutical industrial hubs. Therefore, the study raises concerns on the sources of antibiotic residues into these rivers which can be from both treated as well as untreated sewage,” observed Satish Sinha, Associate Director, Toxics Link.
Antibiotics are important life-saving medicines and play a key role in the wellbeing of human health. However, indiscriminate use and lack of regulatory standards for antibiotics in effluents from pharma industries is leading to this major health hazard, more so for India as India is one of the major users and producers of antibiotics in the world and is more prone to the ill effects of antibiotic pollution,” said Piyush Mohapatra, Senior Programme Coordinator, Toxics Link.